Fox SH - Search Results

1

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.

de Bie RMA, Clarke CE, Espay AJ, Fox SH, Lang AE. de Bie RMA, et al. Among authors: fox sh. Lancet Neurol. 2020 May;19(5):452-461. doi: 10.1016/S1474-4422(20)30036-3. Epub 2020 Mar 12. Lancet Neurol. 2020. PMID: 32171387 Review.

2

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease.

Nash JE, Fox SH, Henry B, Hill MP, Peggs D, McGuire S, Maneuf Y, Hille C, Brotchie JM, Crossman AR. Nash JE, et al. Among authors: fox sh. Exp Neurol. 2000 Sep;165(1):136-42. doi: 10.1006/exnr.2000.7444. Exp Neurol. 2000. PMID: 10964492

3

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.

Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM. Sieradzan KA, et al. Among authors: fox sh. Neurology. 2001 Dec 11;57(11):2108-11. doi: 10.1212/wnl.57.11.2108. Neurology. 2001. PMID: 11739835 Clinical Trial.

4

Potential nondopaminergic drugs for Parkinson's disease.

Silverdale MA, Fox SH, Crossman AR, Brotchie JM. Silverdale MA, et al. Among authors: fox sh. Adv Neurol. 2003;91:273-91. Adv Neurol. 2003. PMID: 12442686 Review. No abstract available.

5

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.

Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM. Henry B, et al. Among authors: fox sh. Exp Neurol. 2003 Oct;183(2):458-68. doi: 10.1016/s0014-4886(03)00064-5. Exp Neurol. 2003. PMID: 14552886

6

Pure cerebello-olivary degeneration of Marie, Foix, and Alajouanine presenting with progressive cerebellar ataxia, cognitive decline, and chorea.

Fox SH, Nieves A, Bergeron C, Lang AE. Fox SH, et al. Mov Disord. 2003 Dec;18(12):1550-4. doi: 10.1002/mds.10606. Mov Disord. 2003. PMID: 14673899

7

A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease.

Tyne HL, Parsons J, Sinnott A, Fox SH, Fletcher NA, Steiger MJ. Tyne HL, et al. Among authors: fox sh. J Neurol. 2004 Nov;251(11):1370-4. doi: 10.1007/s00415-004-0547-4. J Neurol. 2004. PMID: 15592733 Clinical Trial.

8

A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.

Johnston TH, Lee J, Gomez-Ramirez J, Fox SH, Brotchie JM. Johnston TH, et al. Among authors: fox sh. Exp Neurol. 2005 Feb;191(2):243-50. doi: 10.1016/j.expneurol.2004.10.002. Exp Neurol. 2005. PMID: 15649479

9

A writing device improves writing in primary writing tremor.

Espay AJ, Hung SW, Sanger TD, Moro E, Fox SH, Lang AE. Espay AJ, et al. Among authors: fox sh. Neurology. 2005 May 10;64(9):1648-50. doi: 10.1212/01.WNL.0000160390.25028.C3. Neurology. 2005. PMID: 15883338 Clinical Trial.

10

Advances in the delivery of treatments for Parkinson's disease.

Johnston TH, Fox SH, Brotchie JM. Johnston TH, et al. Among authors: fox sh. Expert Opin Drug Deliv. 2005 Nov;2(6):1059-73. doi: 10.1517/17425247.2.6.1059. Expert Opin Drug Deliv. 2005. PMID: 16296809 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters